Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in polyarticular juvenile idiopathic arthritis
NCT00048542Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2002
- Primary completion
- Jan 2005
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 3 trial of Trudexa in polyarticular juvenile idiopathic arthritis, sponsored by Abbott Laboratories. Started Sep 2002; status: completed.
02
Drugs
Trudexa
03
Conditions
polyarticular juvenile idiopathic arthritis
Beyond the preview
Go deeper on NCT00048542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048542.